Exom Group’s Feasibility & Site Selection

Exom Group Srl

Exom Group’s Feasibility & Site Selection

Conducting accurate and effective feasibilities in clinical trials is an investment to ensure a successful study.

Feasibility Studies

Do you know anyone using Exom Group’s Feasibility & Site Selection?

About 35% of delays in studies are due to patient recruitment. Nearly one-fifth of the participating investigators do not enroll any patients, and about one-third only enroll 5% of potential patients. Therefore, conducting accurate and effective feasibilities in clinical trials is crucial for a successful study. Finding the right sites and countries for your study is of utmost importance.

Exom has established a streamlined eFeasibility process, utilizing Exoms Genius SUITE power, supporting you from initial site contact to collection of essential documents for submission to EC/IRB and competent authorities.

Using our Genius eStudy Feasibility & Accelerator Suite we can conduct the entire feasibility process in an average of 38 days, from the preparation of an adequate feasibility questionnaire to first regulatory submission. We help you as a study sponsor identify solutions to mitigate the costs and risks associated with a particular trial.

Exom Group’s Feasibility & Site Selection

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2022 Netspective Media LLC. All Rights Reserved.

Built on Aug 11, 2022 at 1:22pm